Development and Validation of a Machine-Learning Deep Plasma Proteome Classifier for Early-Stage Breast Cancer Detection

Breast Cancer: Targets and Therapy · Published 2026-07-01 · DOI 10.2147/bctt.s609238

Free full text

Authors (17)

Alec Horrmann, Yash Travadi, Jacob Carey, Ella Boytim, Kevin Mallery, Grant Schaap, Carissa Rungkittikhun, Kaylee Judith Kamalanathan, Nathaniel R Bristow, Catalina Galeano-Garces, Adam Groth, Harrison Ball, Alexa R Hesch, Pooja Advani, Justin Hwang, Badrinath R Konety, Justin M Drake

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Horrmann, A., Travadi, Y., Carey, J., et al. (2026). Development and Validation of a Machine-Learning Deep Plasma Proteome Classifier for Early-Stage Breast Cancer Detection. Breast Cancer: Targets and Therapy. https://doi.org/10.2147/bctt.s609238

Related articles

• Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signaling · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Discrimination of Triple-Negative Breast Cancer: A Robust Clinical Baseline versus Multimodal Magnetic Resonance Imaging Integrated Models with Assessment of Generalizability · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for Implementation · Breast Cancer: Targets and Therapy · 2026 · Same journal
• ADPB Sensitivity in Breast Cancer is Correlated with LAT1 Expression: An in vitro Study of a Novel Theranostic Candidate · Breast Cancer: Targets and Therapy · 2026 · Same journal
• AIM2 Lactylation Regulates Radiotherapy Sensitivity in Triple-Negative Breast Cancer · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Combined Treatment with Shuyu Pills and Everolimus Suppresses Triple-Negative Breast Cancer Growth via the PI3K/AKT/mTOR Pathway · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Study · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Lipid Metabolism and Breast Cancer Therapy: An Integrative Literature Review · Breast Cancer: Targets and Therapy · 2026 · Same journal